US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 8.540
  • +0.100+1.18%
Trading Dec 13 12:37 ET
455.83MMarket Cap-4.01P/E (TTM)

Zevra Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
27.63%3.7M
-47.47%4.45M
7.84%3.43M
170.26%27.46M
538.97%12.92M
0.73%2.9M
551.54%8.47M
-19.90%3.18M
-64.53%10.16M
-21.69%2.02M
Operating revenue
27.63%3.7M
-47.47%4.45M
7.84%3.43M
170.26%27.46M
538.97%12.92M
0.73%2.9M
551.54%8.47M
-19.90%3.18M
-64.53%10.16M
-21.69%2.02M
Cost of revenue
1,499.31%2.3M
427.77%3.57M
40.00%175K
1,226.58%2.95M
8,986.36%2M
2.13%144K
1,227.45%677K
1,462.50%125K
-89.22%222K
-62.71%22K
Gross profit
-49.40%1.39M
-88.76%876K
6.52%3.25M
146.66%24.52M
446.05%10.92M
0.66%2.75M
523.94%7.79M
-22.90%3.05M
-62.62%9.94M
-20.73%2M
Operating expense
58.42%28.7M
75.66%24.67M
49.45%23.74M
112.74%74.12M
130.51%26.08M
93.56%18.12M
-46.01%14.05M
173.07%15.88M
84.72%34.84M
110.87%11.31M
Selling and administrative expenses
178.58%16.21M
90.62%12.6M
37.42%9.93M
128.18%34.31M
207.15%14.66M
46.40%5.82M
85.83%6.61M
164.34%7.23M
72.83%15.04M
86.70%4.77M
Research and development costs
-10.99%10.95M
41.54%10.52M
41.85%12.28M
101.01%39.81M
74.61%11.42M
128.36%12.3M
-66.90%7.43M
180.82%8.66M
94.89%19.8M
132.86%6.54M
Depreciation amortization depletion
--1.55M
--1.55M
--1.53M
----
----
--0
--0
--0
----
----
-Depreciation and amortization
--1.55M
--1.55M
--1.53M
----
----
--0
--0
--0
----
----
Operating profit
-77.73%-27.31M
-280.60%-23.8M
-59.66%-20.49M
-99.20%-49.6M
-62.75%-15.16M
-131.87%-15.36M
74.76%-6.25M
-590.21%-12.83M
-422.19%-24.9M
-227.69%-9.31M
Net non-operating interest income expense
-192.06%-1.26M
-235.69%-1.84M
-77.44%194K
158.06%3.04M
-163.41%-546K
1,359.57%1.37M
310.91%1.36M
743.14%860K
1,124.35%1.18M
617.50%861K
Non-operating interest income
-39.64%1.05M
-82.61%270K
-10.84%929K
200.13%4.54M
-79.63%210K
697.25%1.74M
324.32%1.55M
873.83%1.04M
479.69%1.51M
724.80%1.03M
Non-operating interest expense
531.69%2.31M
971.07%2.11M
303.85%735K
348.06%1.5M
344.71%756K
195.16%366K
447.22%197K
3,540.00%182K
-10.90%335K
3,300.00%170K
Other net income (expense)
-222.46%-4.66M
157.00%5.78M
366.86%3.6M
116.72%515K
-128.07%-4.19M
3,349.57%3.8M
802.81%2.25M
-1,115.32%-1.35M
80.90%-3.08M
28,052.83%14.92M
Gain on sale of security
-222.46%-4.66M
157.00%5.78M
366.86%3.6M
-96.47%515K
-128.07%-4.19M
3,349.57%3.8M
802.81%2.25M
-1,115.32%-1.35M
37,489.74%14.58M
28,052.83%14.92M
Special income (charges)
----
----
----
--0
----
----
----
----
-9.74%-17.66M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
9.74%17.66M
--0
Income before tax
-226.05%-33.23M
-650.09%-19.86M
-25.32%-16.69M
-71.79%-46.05M
-407.50%-19.89M
-53.26%-10.19M
89.31%-2.65M
-613.06%-13.32M
-214.58%-26.81M
342.38%6.47M
Income tax
0
194.59%70K
32.04%-70K
0
0
636.36%177K
89.65%-74K
-2,475.00%-103K
-197.06%-33K
2,014.71%719K
Net income
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-72.00%-46.05M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
-212.94%-26.77M
312.73%5.75M
Net income continuous Operations
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-72.00%-46.05M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
-212.94%-26.77M
312.73%5.75M
Minority interest income
Net income attributable to the parent company
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-72.00%-46.05M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
-212.94%-26.77M
312.73%5.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-72.00%-46.05M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
57.44%-26.77M
312.73%5.75M
Basic earnings per share
-130.00%-0.69
-500.00%-0.48
-5.26%-0.4
-66.67%-1.3
-437.50%-0.54
-57.89%-0.3
88.57%-0.08
-660.00%-0.38
63.03%-0.78
220.00%0.16
Diluted earnings per share
-130.00%-0.69
-500.00%-0.48
-5.26%-0.4
-66.67%-1.3
-437.50%-0.54
-57.89%-0.3
88.57%-0.08
-660.00%-0.38
63.03%-0.78
220.00%0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 27.63%3.7M-47.47%4.45M7.84%3.43M170.26%27.46M538.97%12.92M0.73%2.9M551.54%8.47M-19.90%3.18M-64.53%10.16M-21.69%2.02M
Operating revenue 27.63%3.7M-47.47%4.45M7.84%3.43M170.26%27.46M538.97%12.92M0.73%2.9M551.54%8.47M-19.90%3.18M-64.53%10.16M-21.69%2.02M
Cost of revenue 1,499.31%2.3M427.77%3.57M40.00%175K1,226.58%2.95M8,986.36%2M2.13%144K1,227.45%677K1,462.50%125K-89.22%222K-62.71%22K
Gross profit -49.40%1.39M-88.76%876K6.52%3.25M146.66%24.52M446.05%10.92M0.66%2.75M523.94%7.79M-22.90%3.05M-62.62%9.94M-20.73%2M
Operating expense 58.42%28.7M75.66%24.67M49.45%23.74M112.74%74.12M130.51%26.08M93.56%18.12M-46.01%14.05M173.07%15.88M84.72%34.84M110.87%11.31M
Selling and administrative expenses 178.58%16.21M90.62%12.6M37.42%9.93M128.18%34.31M207.15%14.66M46.40%5.82M85.83%6.61M164.34%7.23M72.83%15.04M86.70%4.77M
Research and development costs -10.99%10.95M41.54%10.52M41.85%12.28M101.01%39.81M74.61%11.42M128.36%12.3M-66.90%7.43M180.82%8.66M94.89%19.8M132.86%6.54M
Depreciation amortization depletion --1.55M--1.55M--1.53M----------0--0--0--------
-Depreciation and amortization --1.55M--1.55M--1.53M----------0--0--0--------
Operating profit -77.73%-27.31M-280.60%-23.8M-59.66%-20.49M-99.20%-49.6M-62.75%-15.16M-131.87%-15.36M74.76%-6.25M-590.21%-12.83M-422.19%-24.9M-227.69%-9.31M
Net non-operating interest income expense -192.06%-1.26M-235.69%-1.84M-77.44%194K158.06%3.04M-163.41%-546K1,359.57%1.37M310.91%1.36M743.14%860K1,124.35%1.18M617.50%861K
Non-operating interest income -39.64%1.05M-82.61%270K-10.84%929K200.13%4.54M-79.63%210K697.25%1.74M324.32%1.55M873.83%1.04M479.69%1.51M724.80%1.03M
Non-operating interest expense 531.69%2.31M971.07%2.11M303.85%735K348.06%1.5M344.71%756K195.16%366K447.22%197K3,540.00%182K-10.90%335K3,300.00%170K
Other net income (expense) -222.46%-4.66M157.00%5.78M366.86%3.6M116.72%515K-128.07%-4.19M3,349.57%3.8M802.81%2.25M-1,115.32%-1.35M80.90%-3.08M28,052.83%14.92M
Gain on sale of security -222.46%-4.66M157.00%5.78M366.86%3.6M-96.47%515K-128.07%-4.19M3,349.57%3.8M802.81%2.25M-1,115.32%-1.35M37,489.74%14.58M28,052.83%14.92M
Special income (charges) --------------0-----------------9.74%-17.66M--0
-Less:Other special charges --------------------------------9.74%17.66M--0
Income before tax -226.05%-33.23M-650.09%-19.86M-25.32%-16.69M-71.79%-46.05M-407.50%-19.89M-53.26%-10.19M89.31%-2.65M-613.06%-13.32M-214.58%-26.81M342.38%6.47M
Income tax 0194.59%70K32.04%-70K00636.36%177K89.65%-74K-2,475.00%-103K-197.06%-33K2,014.71%719K
Net income -220.49%-33.23M-674.39%-19.93M-25.76%-16.62M-72.00%-46.05M-445.95%-19.89M-56.70%-10.37M89.30%-2.57M-609.07%-13.22M-212.94%-26.77M312.73%5.75M
Net income continuous Operations -220.49%-33.23M-674.39%-19.93M-25.76%-16.62M-72.00%-46.05M-445.95%-19.89M-56.70%-10.37M89.30%-2.57M-609.07%-13.22M-212.94%-26.77M312.73%5.75M
Minority interest income
Net income attributable to the parent company -220.49%-33.23M-674.39%-19.93M-25.76%-16.62M-72.00%-46.05M-445.95%-19.89M-56.70%-10.37M89.30%-2.57M-609.07%-13.22M-212.94%-26.77M312.73%5.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -220.49%-33.23M-674.39%-19.93M-25.76%-16.62M-72.00%-46.05M-445.95%-19.89M-56.70%-10.37M89.30%-2.57M-609.07%-13.22M57.44%-26.77M312.73%5.75M
Basic earnings per share -130.00%-0.69-500.00%-0.48-5.26%-0.4-66.67%-1.3-437.50%-0.54-57.89%-0.388.57%-0.08-660.00%-0.3863.03%-0.78220.00%0.16
Diluted earnings per share -130.00%-0.69-500.00%-0.48-5.26%-0.4-66.67%-1.3-437.50%-0.54-57.89%-0.388.57%-0.08-660.00%-0.3863.03%-0.78220.00%0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.